ATX-01 (Arthex Biotech)

N/A

Report date: 2026/05/13 20:02:10

NME

Base Information

Drug NameATX-01 (Arthex Biotech)

Drug Alias Namea lyophilized modified oligonucleotide of 16 nucleotides conjugated to a molecule of oleic acidantagomiR-23bAntimiR-23bARTHEx 01ARTHEx-01 +[7]

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionMicroRNAs inhibitors

TargetsMicroRNAs

Therapy Area/IndicationsMyotonic DystrophyOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSpain

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesArthex Biotech SL

China Registration ClassN/A

Develop Information

Active CompaniesArthex Biotech SL

Inactive CompaniesN/A

Active IndicationsMyotonic DystrophyOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A